Signet Investment Advisory Group Inc. Sells 160 Shares of The Clorox Company (NYSE:CLX)

Signet Investment Advisory Group Inc. reduced its stake in The Clorox Company (NYSE:CLXFree Report) by 3.7% during the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 4,114 shares of the company’s stock after selling 160 shares during the period. Signet Investment Advisory Group Inc.’s holdings in Clorox were worth $670,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds and other institutional investors also recently made changes to their positions in CLX. GHP Investment Advisors Inc. boosted its holdings in Clorox by 2.0% in the second quarter. GHP Investment Advisors Inc. now owns 3,634 shares of the company’s stock worth $496,000 after acquiring an additional 72 shares in the last quarter. Fiduciary Group LLC raised its position in shares of Clorox by 0.4% during the second quarter. Fiduciary Group LLC now owns 19,050 shares of the company’s stock worth $2,600,000 after purchasing an additional 72 shares during the period. SPC Financial Inc. lifted its holdings in shares of Clorox by 2.2% in the 2nd quarter. SPC Financial Inc. now owns 3,485 shares of the company’s stock worth $476,000 after purchasing an additional 75 shares in the last quarter. Massmutual Trust Co. FSB ADV grew its position in Clorox by 17.2% in the 3rd quarter. Massmutual Trust Co. FSB ADV now owns 510 shares of the company’s stock valued at $83,000 after purchasing an additional 75 shares during the period. Finally, Mesirow Financial Investment Management Inc. increased its stake in Clorox by 5.1% during the 2nd quarter. Mesirow Financial Investment Management Inc. now owns 1,702 shares of the company’s stock valued at $233,000 after purchasing an additional 83 shares in the last quarter. 78.53% of the stock is owned by institutional investors.

Analyst Upgrades and Downgrades

CLX has been the topic of a number of analyst reports. Citigroup upped their target price on shares of Clorox from $165.00 to $170.00 and gave the stock a “neutral” rating in a report on Friday, September 6th. Jefferies Financial Group upgraded Clorox from a “hold” rating to a “buy” rating and raised their target price for the company from $174.00 to $187.00 in a report on Tuesday, October 1st. Barclays upped their price target on Clorox from $130.00 to $137.00 and gave the stock an “underweight” rating in a report on Friday, October 11th. Evercore ISI dropped their price objective on Clorox from $140.00 to $139.00 and set an “underperform” rating on the stock in a research note on Monday, October 14th. Finally, BNP Paribas upgraded shares of Clorox to a “strong sell” rating in a research note on Friday, September 6th. Six investment analysts have rated the stock with a sell rating, nine have given a hold rating and one has issued a buy rating to the company’s stock. According to MarketBeat.com, the company has a consensus rating of “Hold” and an average price target of $150.14.

Read Our Latest Analysis on Clorox

Clorox Stock Performance

NYSE:CLX opened at $156.69 on Friday. The company has a market capitalization of $19.46 billion, a P/E ratio of 81.19, a P/E/G ratio of 3.19 and a beta of 0.41. The business has a fifty day simple moving average of $160.51 and a two-hundred day simple moving average of $145.52. The company has a debt-to-equity ratio of 5.04, a current ratio of 1.03 and a quick ratio of 0.63. The Clorox Company has a 1 year low of $114.68 and a 1 year high of $169.09.

Clorox (NYSE:CLXGet Free Report) last announced its quarterly earnings data on Thursday, August 1st. The company reported $1.82 earnings per share for the quarter, topping the consensus estimate of $1.54 by $0.28. The company had revenue of $1.90 billion during the quarter, compared to analyst estimates of $1.97 billion. Clorox had a return on equity of 281.12% and a net margin of 3.95%. On average, analysts expect that The Clorox Company will post 6.64 earnings per share for the current year.

Clorox Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Thursday, November 7th. Investors of record on Wednesday, October 23rd will be paid a dividend of $1.22 per share. This represents a $4.88 dividend on an annualized basis and a dividend yield of 3.11%. The ex-dividend date is Wednesday, October 23rd. Clorox’s payout ratio is currently 252.85%.

Insider Activity at Clorox

In other Clorox news, EVP Angela C. Hilt sold 1,733 shares of the stock in a transaction on Friday, September 6th. The stock was sold at an average price of $165.52, for a total transaction of $286,846.16. Following the sale, the executive vice president now owns 13,471 shares in the company, valued at $2,229,719.92. This represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this link. 0.51% of the stock is owned by company insiders.

Clorox Profile

(Free Report)

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.

See Also

Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Clorox Company (NYSE:CLXFree Report).

Institutional Ownership by Quarter for Clorox (NYSE:CLX)

Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.